OXiGENE Announces Second Quarter 2008 Earnings Conference Call and Webcast
WALTHAM, Mass., July 28, 2008 (PRIME NEWSWIRE) -- OXiGENE, Inc. (Nasdaq:OXGN)
(XSSE:OXGN), a clinical-stage, biopharmaceutical company developing novel
therapeutics to treat cancer and eye diseases, will report second quarter 2008
results on Monday, August 4, 2008. A conference call and webcast hosted by
OXiGENE management will begin at 2:00 p.m. EDT (11:00 a.m. PDT).
To listen to a live or an archived version of the audio webcast, please log on
to the Company's website, www.oxigene.com. Under the "Investor Center" tab,
select the link to "Presentations & Conference Calls."
OXiGENE's earnings conference call can also be heard live by dialing (888)
208-1507 in the United States and Canada, and (913) 312-0402 for international
callers, five minutes prior to the beginning of the call. A replay will be
available starting at 5:00 p.m., EDT (2:00 p.m., PDT) on August 4, 2008 and
ending at 5:00 p.m. EDT (2:00 p.m., PDT) on Monday, August 11, 2008. To access
the replay, please dial (888) 203-1112 if calling from the United States or
Canada, or (719) 457-0820 from international locations. Please refer to replay
pass code 6113741.
About OXiGENE
OXiGENE is a clinical-stage biopharmaceutical company developing novel
therapeutics to treat cancer and eye diseases. The company's major focus is
developing vascular disrupting agents (VDAs) that selectively disrupt abnormal
blood vessels associated with solid tumor progression and visual impairment.
OXiGENE is dedicated to leveraging its intellectual property and therapeutic
development expertise to bring life-extending and life-enhancing medicines to
patients.
The OXiGENE, Inc. logo is available at
http://www.primenewswire.com/newsroom/prs/?pkgid=4969
CONTACT: OXiGENE, Inc.
Investor and Media Contact:
Michelle Edwards, Investor Relations
medwards@oxigene.com
415-315-9413
OXiGENE Announces Second Quarter 2008 Earnings Conference Call and Webcast
| Source: Oxigene, Inc.